97296549 - NUCLEAR-DELIVERED ANTIBODY-DRUG CONJUGATES

Information

• Trademark
• 97296549

• Source

• Serial Number

  97296549

• Registration Number

  7064074

• International Classifications

  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  March 04, 2022
  2 years ago

• Registration Date

  May 23, 2023
  a year ago

• Transaction Date

  May 23, 2023
  a year ago

• Status Date

  May 23, 2023
  a year ago

• Location Date

  May 23, 2023
  a year ago

• First Use Anywhere Date

  January 10, 2020
  4 years ago

• First Use In Commerce Date

  January 10, 2020
  4 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BAL, KAMAL SINGH

• Attorney Docket Number

  52628-TM1007

  Attorney Name

  Chelsea E. Carbone

  Law Office Assigned Location Code

  N70

• Owners

  • Angiex, Inc.

Case File Statements

• GS0421: Scientific research and development in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; research and product development services for others in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine; Medical and scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, and cardiovascular disease detection; Providing information on the subject of scientific research in the fields of cancer, immunological-inflammatory conditions, tissue repair, eye diseases, cardiovascular disease, biology, laboratory testing, biotechnology, biochemistry, and medicine

Case File Event Statements

• 5/23/2023 - a year ago

  25 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCS

• 5/23/2023 - a year ago

  24 - REGISTERED-SUPPLEMENTAL REGISTER Type: R.SR

• 4/21/2023 - a year ago

  23 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 4/21/2023 - a year ago

  22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 4/21/2023 - a year ago

  21 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF

• 4/21/2023 - a year ago

  20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 4/21/2023 - a year ago

  19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 4/21/2023 - a year ago

  18 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 4/17/2023 - a year ago

  17 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 4/12/2023 - a year ago

  16 - ASSIGNED TO LIE Type: ALIE

• 3/31/2023 - a year ago

  15 - NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Type: AAUA

• 3/30/2023 - a year ago

  14 - APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER Type: CNTA

• 3/30/2023 - a year ago

  13 - USE AMENDMENT ACCEPTED Type: IUAA

• 3/7/2023 - a year ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 3/6/2023 - a year ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 3/6/2023 - a year ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 3/7/2023 - a year ago

  9 - AMENDMENT TO USE PROCESSING COMPLETE Type: AUPC

• 3/7/2023 - a year ago

  8 - USE AMENDMENT FILED Type: IUAF

• 3/6/2023 - a year ago

  7 - TEAS AMENDMENT OF USE RECEIVED Type: EAAU

• 12/22/2022 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 12/22/2022 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 12/22/2022 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/15/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/9/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/8/2022 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP